Breaking News

OncoGenerix & Alpha Capital to Build Injectables Factory in the U.S.

New project launches during ONGX Token STO Campaign.

By: Contract Pharma

Contract Pharma Staff

Novel and generics pharma producer OncoGenerix and Alpha Capital LLC have come to an agreement to build a new injectable pharmaceutical factory in the U.S. The production facility will serve as an affiliate factory, similar to the one that OncoGenerix already operates in China.   Alpha Capital LLC is considering a Georgia Opportunity Zone as the location for the new plant. The output capacity of the project is expected to reach 20 million vials of injectable oncology products and vaccines.   ONG...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters